The virus infects cholangiocytes with elevated levels of IL1, TNFA, and MCP1, all potential factors that can induce the development of MASH with progression to advanced chronic states, but we cannot exclude possible cancerous states [171]. This evidence concerns the gene CCL2 and metabolic dysfunction-associated steatohepatitis.